SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $590,000 | +8.3% | 3,015 | -6.1% | 0.01% | 0.0% |
Q2 2020 | $545,000 | +18.7% | 3,210 | -19.2% | 0.01% | +11.1% |
Q1 2020 | $459,000 | -4.4% | 3,975 | -5.3% | 0.01% | +12.5% |
Q4 2019 | $480,000 | +16.8% | 4,197 | -12.8% | 0.01% | +14.3% |
Q3 2019 | $411,000 | +23.4% | 4,812 | 0.0% | 0.01% | +16.7% |
Q2 2019 | $333,000 | -2.9% | 4,812 | -2.0% | 0.01% | 0.0% |
Q1 2019 | $343,000 | +15.9% | 4,912 | -5.8% | 0.01% | 0.0% |
Q4 2018 | $296,000 | -34.4% | 5,217 | -10.8% | 0.01% | -25.0% |
Q3 2018 | $451,000 | -6.8% | 5,849 | -19.8% | 0.01% | -11.1% |
Q2 2018 | $484,000 | +27.0% | 7,291 | +0.2% | 0.01% | +12.5% |
Q1 2018 | $381,000 | +7.0% | 7,279 | +9.3% | 0.01% | +14.3% |
Q4 2017 | $356,000 | +8.9% | 6,660 | +10.7% | 0.01% | +16.7% |
Q3 2017 | $327,000 | +13.1% | 6,017 | +7.6% | 0.01% | -14.3% |
Q2 2017 | $289,000 | -36.3% | 5,590 | -22.6% | 0.01% | -36.4% |
Q1 2017 | $454,000 | +19.2% | 7,225 | -0.3% | 0.01% | +22.2% |
Q4 2016 | $381,000 | +0.8% | 7,247 | +3.2% | 0.01% | 0.0% |
Q3 2016 | $378,000 | +65.1% | 7,022 | +23.4% | 0.01% | +28.6% |
Q2 2016 | $229,000 | +54.7% | 5,692 | +34.0% | 0.01% | +40.0% |
Q1 2016 | $148,000 | -11.9% | 4,249 | +12.6% | 0.01% | 0.0% |
Q4 2015 | $168,000 | +20.0% | 3,775 | +2.8% | 0.01% | 0.0% |
Q3 2015 | $140,000 | -9.7% | 3,673 | +13.4% | 0.01% | 0.0% |
Q2 2015 | $155,000 | +103.9% | 3,239 | +49.6% | 0.01% | +150.0% |
Q1 2015 | $76,000 | -10.6% | 2,165 | -18.8% | 0.00% | -33.3% |
Q4 2014 | $85,000 | -6.6% | 2,665 | +8.1% | 0.00% | 0.0% |
Q3 2014 | $91,000 | -3.2% | 2,465 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $94,000 | +51.6% | 2,465 | +79.3% | 0.00% | +50.0% |
Q1 2014 | $62,000 | -1.6% | 1,375 | -15.4% | 0.00% | 0.0% |
Q4 2013 | $63,000 | +8.6% | 1,625 | +22.6% | 0.00% | -33.3% |
Q3 2013 | $58,000 | +41.5% | 1,325 | 0.0% | 0.00% | +50.0% |
Q2 2013 | $41,000 | – | 1,325 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |